This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Neuropsychotherapist, A New Resource Documenting The Mental Health Renaissance Of The 21st Century, Promises To Be Indispensable Tool For Therapists Looking To Embrace Multidisciplinary Approach To Psychotherapy

BRISBANE, Australia, April 1, 2013 /PRNewswire/ -- There is a significant shift in mental health toward a multidisciplinary understanding of the psyche, and a new website, magazine and journal are leading the way to inform therapists of these changes. The Neuropsychotherapist platform has been designed to inform therapists of the dynamic interplay between the mind, body, social interaction and the environment as they impact on a person's well-being. By understanding the mechanisms of our biology, the processes of our psychology, and the influences of social interaction, it is believed a holistic therapeutic practice can be formulated.

The new platform consists of a website,, boasting articles across a broad range of subjects that impact on mental health and, more specifically, psychotherapy; a quarterly e-magazine of feature articles, departments and regular columns; and an open-access scientific journal – The International Journal of Neuropsychotherapy.

The Neuropsychotherapist has a host of world-renowned specialists on its advisory board and panel of experts, including Allan Schore, Louis Cozolino, Iain McGilchrist, Mark Solms, and Todd Feinberg, just to name a few.

One of the feature attractions of the website is "Big Questions" – an activity where a socially significant question is periodically posed to the international "Panel of Experts." Experts in various fields, such as neurology, psychology, psychiatry, and philosophy, weigh in on the question with their unique perspectives.

"The Neuropsychotherapist is an innovative, exciting, groundbreaking venture. It is sure to be a leader in disseminating important new information in a burgeoning scientific field." – Professor Todd Feinberg, New York neurologist, psychiatrist, and award-winning author.

The Neuropsychotherapist will be an important hub of information, and a network of therapists, researchers and educators who are riding the new wave of the mental health renaissance.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,719.92 -78.57 -0.44%
S&P 500 2,080.41 -9.70 -0.46%
NASDAQ 5,108.6660 -18.8590 -0.37%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs